EarliTec Diagnostics, Inc. — SEC Form D Filing
EarliTec Diagnostics, Inc. filed an SEC Form D on April 30, 2026, reporting $3.50M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- April 30, 2026
- Amount reported
- $3.50M
- Industry
- Health Care
- Website
- https://earlipointhealth.com/
What the company does
Securities: Debt. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Early assessment of autism in children faces barriers and there is a need for clear diagnostic tools to evaluate social and cognitive development.
Solution
The company provides an FDA-cleared autism diagnostic device that captures eye gaze data and uses proprietary algorithms to analyze patterns of visual attention, generating insights to support early detection and track progress.
Verdict
Investors said yes at that moment because EarliTec's FDA-cleared device addressed an urgent need for early autism diagnosis, not because other existing solutions were demonstrably inadequate. They implicitly bet on the growing emphasis on early interventions within childhood development and the belief that technological advancements could redefine diagnostic methodologies. However, the limited upside lies in the potential for competition from new entrants and the challenge of scaling within the complex healthcare landscape, which might dampen long-term durability.
Source: SEC EDGAR Form D filing